Storax Attenuates Cardiac Fibrosis following Acute Myocardial Infarction in Rats via Suppression of AT1R–Ankrd1–P53 Signaling Pathway

Myocardial fibrosis following acute myocardial infarction (AMI) seriously affects the prognosis and survival rate of patients. This study explores the role and regulation mechanism of storax, a commonly used traditional Chinese medicine for treatment of cardiovascular diseases, on myocardial fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhuo, Lu, Danni, Yuan, Jianmei, Wang, Liying, Wang, Jiajun, Lei, Ziqin, Liu, Si, Wu, Junjie, Wang, Jian, Huang, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657855/
https://www.ncbi.nlm.nih.gov/pubmed/36361958
http://dx.doi.org/10.3390/ijms232113161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657855/
https://www.ncbi.nlm.nih.gov/pubmed/36361958
http://dx.doi.org/10.3390/ijms232113161

Ejemplares similares